Skip to content
10-K

Annual Report

LifeMD, Inc. LFMD LFMDP

0001493152-26-009549

← back to feed
Filed
Mar 10, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 9, 2026 47.97M sh
Shares Diluted FY 2025 · Dec 31, 2025 45.13M sh
Shares Diluted FY 2025 · Dec 31, 2024 41.2M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $270K
Capex FY 2025 · Dec 31, 2025 $1.87M
Capex restated FY 2025 · Dec 31, 2024 $1.46M
Operating Cash Flow FY 2025 · Dec 31, 2025 $8.28M
Operating Cash Flow FY 2025 · Dec 31, 2024 $17.51M
Stockholders Equity FY 2025 · Dec 31, 2025 $23.16M
Stockholders Equity restated FY 2025 · Dec 31, 2024 −$9.08M
Current Liabilities FY 2025 · Dec 31, 2025 $41.57M
Current Liabilities restated FY 2025 · Dec 31, 2024 $67.4M
Total Liabilities FY 2025 · Dec 31, 2025 $47.25M
Total Liabilities restated FY 2025 · Dec 31, 2024 $83.65M
Current Assets FY 2025 · Dec 31, 2025 $51.83M
Current Assets restated FY 2025 · Dec 31, 2024 $52.37M
Total Assets FY 2025 · Dec 31, 2025 $70.41M
Total Assets restated FY 2025 · Dec 31, 2024 $76.1M
Eps Diluted FY 2025 · Dec 31, 2025 $0.25
Eps Diluted FY 2025 · Dec 31, 2024 −$0.60
Eps Basic FY 2025 · Dec 31, 2025 $0.25
Eps Basic FY 2025 · Dec 31, 2024 −$0.60
Sga Expense FY 2025 · Dec 31, 2025 $57.94M
Sga Expense restated FY 2025 · Dec 31, 2024 $57.95M
Net Income FY 2025 · Dec 31, 2025 $14.35M
Net Income restated FY 2025 · Dec 31, 2024 −$21.41M
Operating Income FY 2025 · Dec 31, 2025 −$7.67M
Operating Income restated FY 2025 · Dec 31, 2024 −$20.4M
Gross Profit FY 2025 · Dec 31, 2025 $166.34M
Gross Profit restated FY 2025 · Dec 31, 2024 $133.38M
Cost Of Revenue FY 2025 · Dec 31, 2025 $27.71M
Cost Of Revenue restated FY 2025 · Dec 31, 2024 $21.44M
Revenue FY 2025 · Dec 31, 2025 $194.06M
Revenue restated FY 2025 · Dec 31, 2024 $154.82M
Stock Issued FY 2025 · May 29, 2025 388.65K sh
Stock Issued FY 2025 · Nov 15, 2023 79.33K sh